☆ 4.8 Article

Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol

CELL RESEARCH (2019)

期刊

CELL RESEARCH

卷 29, 期 2, 页码 151-166

出版社

NATURE PUBLISHING GROUP

DOI: 10.1038/s41422-018-0123-6

关键词

类别

Cell Biology

资金

National Natural Science Foundation [81870607, 81670796, 81430020, 81230018, 81300644, 31640020]
National Key R&D Program of China [SQ2017YFSF090203]

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

摘要

Menopause is associated with dyslipidemia and an increased risk of cardio-cerebrovascular disease. The classic view assumes that the underlying mechanism of dyslipidemia is attributed to an insufficiency of estrogen. In addition to a decrease in estrogen, circulating follicle-stimulating hormone (FSH) levels become elevated at menopause. In this study, we find that blocking FSH reduces serum cholesterol via inhibiting hepatic cholesterol biosynthesis. First, epidemiological results show that the serum FSH levels are positively correlated with the serum total cholesterol levels, even after adjustment by considering the effects of serum estrogen. In addition, the prevalence of hypercholesterolemia is significantly higher in peri-menopausal women than that in premenopausal women. Furthermore, we generated a mouse model of FSH elevation by intraperitoneally injecting exogenous FSH into ovariectomized (OVX) mice, in which a normal level of estrogen (E2) was maintained by exogenous supplementation. Consistently, the results indicate that FSH, independent of estrogen, increases the serum cholesterol level in this mouse model. Moreover, blocking FSH signaling by anti-FSH beta antibody or ablating the FSH receptor (FSHR) gene could effectively prevent hypercholesterolemia induced by FSH injection or high-cholesterol diet feeding. Mechanistically, FSH, via binding to hepatic FSHRs, activates the Gi2 alpha/beta-arrestin-2/Akt pathway and subsequently inhibits the binding of FoxO1 with the SREBP-2 promoter, thus preventing FoxO1 from repressing SREBP-2 gene transcription. This effect, in turn, results in the upregulation of SREBP- 2, which drives HMGCR nascent transcription and de novo cholesterol biosynthesis, leading to the increase of cholesterol accumulation. This study uncovers that blocking FSH signaling might be a new strategy for treating hypercholesterolemia during menopause, particularly for women in peri-menopause characterized by FSH elevation only.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

主要评分

4.8

评分不足

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

The Compound U18666A Inhibits the Intoxication of Cells by Clostridioides difficile Toxins TcdA and TcdB

Panagiotis Papatheodorou, Selina Kindig, Adriana Badilla-Lobo, Stephan Fischer, Ebru Durgun, Tharani Thuraisingam, Alexander Witte, Shuo Song, Klaus Aktories, Esteban Chaves-Olarte, Cesar Rodriguez, Holger Barth

Summary: The intestinal pathogen Clostridioides difficile produces two large exotoxins, toxin A and toxin B, which cause clinical symptoms of C. difficile-associated diseases. Inhibiting the cellular uptake and mode of action of these toxins is a promising therapeutic strategy. The sterol regulatory element-binding protein 2 pathway and membrane cholesterol play crucial roles in the intoxication of cells by TcdA and TcdB, offering potential targets for novel antitoxin strategies.

FRONTIERS IN MICROBIOLOGY (2021)